Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Robert B. Polak
Introduction
Robert B. Polak is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing gastrointestinal issues and skin conditions. His innovative approach has led to the development of a unique method for treating H. pylori and dermatitis.
Latest Patents
Polak holds a patent for a method and compositions for the treatment of H. pylori and dermatitis. This patent describes a method of treating mammals for the presence or activity of H. pylori in the gastrointestinal tract. The method involves orally administering a sufficient amount of a scavenging, reacting, or inactivating compound to remove bicarbonate ions, ammonium ions, or urea that are present in combination with the microorganisms that infect the gastric mucosa. These microorganisms are known to be implicated in gastritis, gastric ulcer disease, and as a risk factor in gastric carcinoma. Additionally, the invention includes a method for the treatment or prevention of dermatitis, such as diaper rash, where these compounds are preapplied to the skin or used to treat the diaper prior to use.
Career Highlights
Polak is associated with Urecap Corporation, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in the advancement of treatment methodologies.
Collaborations
Polak collaborates with Attallah Kappas, contributing to the innovative projects at Urecap Corporation. Their combined expertise enhances the potential for groundbreaking advancements in their field.
Conclusion
Robert B. Polak's contributions to medical innovation, particularly through his patent for treating H. pylori and dermatitis, highlight his commitment to improving health outcomes. His work at Urecap Corporation and collaboration with fellow inventor Attallah Kappas further exemplify the impact of his inventions in the medical community.